Yesterday, we bought call options on Catalyst Pharmaceuticals Inc. (Nasdaq: CPRX). In the trade alert, I described it as a “rare bird” in the biotech and pharmaceuticals space.
Read MoreLast November was a “hold your breath” moment for financial markets, as everyone waited to learn the outcome of the U.S. presidential election. Once it was more or less resolved, we saw a new wave of sector-specific trends unleashed.
Read MoreFirst, if you’ve been with me since the “B.C.” days (that is, Before Coronavirus) … congratulations on the 60% profit you locked in on the “short volatility” trade we made on March 20, 2020.
Read MoreFirst, congratulations on your 60%-plus profit on your SPDR Utilities Sector ETF (NYSE: XLU) play! I wrote two weeks ago about the potential for interest rates to turn lower and how that would put a tailwind behind the utilities sector.
Read MoreI’ll touch on all of our open positions today, but I’ll start with Supernus Pharmaceuticals (Nasdaq: SUPN).
Read More
Enter your username and password below